NLRP6 Induces Lung Injury and Inflammation Early in Brucella and Influenza Coinfection

Bochang Shi1, Hui Han1,2, Huabin Li3

  • 1Inner Mongolia Key Laboratory of Molecular Biology, Inner Mongolia Medical University, Hohhot 010000, China.

Insights

Brucella and influenza coinfection severely damages lungs and increases mortality. Targeting NLRP6 protein may offer a new treatment for these coinfections.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Brucellosis epidemics are increasing, raising concerns about coinfections with influenza virus.
  • The mechanisms and pathogenicity of brucella-influenza coinfections remain poorly understood.

Purpose of the Study:

  • To investigate the impact of brucella and influenza coinfection on lung damage and mortality.
  • To elucidate the role of NLRP6 in the host response to coinfection.

Main Methods:

  • A mouse model of brucella and influenza coinfection was used.
  • Wild-type (WT) and NLRP6 knockout (NLRP6-/-) mice were compared.
  • Disease progression, mortality, bacterial load, lung histology, and inflammatory markers (IL-18) were assessed.

Main Results:

  • Coinfection led to severe respiratory symptoms, weight loss, and high mortality in WT mice.
  • Influenza synergistically enhanced brucella proliferation, causing extensive lung tissue destruction and inflammation.
  • NLRP6 deletion attenuated lung injury, reduced bacterial load, and decreased IL-18 expression.

Conclusions:

  • NLRP6 plays a critical role in the pathogenesis of brucella-influenza coinfection.
  • NLRP6 and IL-18 are potential therapeutic targets for managing these coinfections.

Related Concept Videos